These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 21397977)

  • 1. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
    vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
    Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin.
    Huber M; Vor Dem Esche U; Grunow R; Bessler WG
    Drugs Exp Clin Res; 2005; 31(2):35-43. PubMed ID: 15929604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694.
    Laffly E; Danjou L; Condemine F; Vidal D; Drouet E; Lefranc MP; Bottex C; Thullier P
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3414-20. PubMed ID: 16048955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
    Little SF; Webster WM; Fisher DE
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics.
    Kulshreshtha P; Tiwari A; Priyanka ; Joon S; Sinha S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):185-93. PubMed ID: 26364143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
    Price BM; Liner AL; Park S; Leppla SH; Mateczun A; Galloway DR
    Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
    Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
    Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
    Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
    Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibodies to B.anthracis protective antigen are capable to neutralize and to enhance the anthrax lethal toxin action in vitro].
    Belova EV; Dubileĭ SA; Kravchenko TB; Kolesnikov AV; Zakharova MIu; Shemiakin IG
    Mol Gen Mikrobiol Virusol; 2004; (3):21-6. PubMed ID: 15354937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
    Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-derived, plant-produced monoclonal antibody for the treatment of anthrax.
    Hull AK; Criscuolo CJ; Mett V; Groen H; Steeman W; Westra H; Chapman G; Legutki B; Baillie L; Yusibov V
    Vaccine; 2005 Mar; 23(17-18):2082-6. PubMed ID: 15755575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W
    Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.
    Pohl MA; Rivera J; Nakouzi A; Chow SK; Casadevall A
    Infect Immun; 2013 Jun; 81(6):1880-8. PubMed ID: 23509144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
    Maynard JA; Maassen CB; Leppla SH; Brasky K; Patterson JL; Iverson BL; Georgiou G
    Nat Biotechnol; 2002 Jun; 20(6):597-601. PubMed ID: 12042864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model.
    Zhao P; Liang X; Kalbfleisch J; Koo HM; Cao B
    Hum Antibodies; 2003; 12(4):129-35. PubMed ID: 15156101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.